The study shows the heart team is “working,” say some, but one surgeon says TAVI use is still worryingly high in this group.

With one positive and one neutral trial, the jury is still out on whether intra-arterial hypothermia boosts functional outcomes.

The analysis, based on Medicare data, also showed women have higher risks of complications and early mortality than men.

The blood or saliva test results can be used as a “risk enhancer” for patients who fall in treatment gray zones, study author ...

Rick Nishimura and Michael Mack outline the evolving role of surgery in the treatment of severe tricuspid regurgitation ...

South London data show stroke became more common in Black African and Caribbean people but stayed steady in white peers.

Topline results announced today show gains in KCCQ and peak oxygen consumption—the full dataset is coming soon.

Considering some unique trial features, the results should be seen “more as hypothesis-generating than practice-changing.” ...

Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but ...

Glucagon-like peptide-1 (GLP-1) receptor agonists may improve cardiovascular outcomes in the year following TAVI for aortic ...

The excess risk persisted after discharge, suggesting the need for closer follow-up and intensified secondary prevention.

Held by the European Society of Cardiology, the meeting features developments in basic science, diagnosis, and management.